Literature DB >> 17610113

Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy.

Li Zhou1, Jing-An Rui2, Shao-Bin Wang1, Shu-Guang Chen1, Qiang Qu1, Tian-Yi Chi1, Xue Wei1, Kai Han1, Ning Zhang1, Hai-Tao Zhao1.   

Abstract

BACKGROUND: Radical major hepatectomy (RMH) has been suggested as one of main options for cure of large/advanced hepatocellular carcinoma (HCC). However, its operative risk remains high and its effectiveness is still controversial, especially for patients with liver cirrhosis. The present study aims to investigate short- and long-term outcomes and to identify prognostic factors for cirrhotic patients with HCC after RMH.
MATERIALS AND METHODS: Prospectively collected clinicopathological data of 81 consecutive cirrhotic HCC patients who underwent RMH were reviewed retrospectively. The Kaplan-Meier method was adopted for evaluating long-term survival. Prognostic factors were identified by univariate and multivariate analyses.
RESULTS: After RMH, perioperative mortality, overall morbidity, and life-threatening morbidity were 1.2%, 24.7%, and 12.3%, respectively. Overall and disease-free 5-year survival rates were 39.4% and 28.1%, respectively. Univariate analysis showed that presence of portal vein tumor thrombosis (PVTT) and satellite nodules, late TNM staging, high Edmondson-Steiner grading, and blood transfusion was associated with worsened prognosis. Of them, Edmondson-Steiner grading was identified as the sole independent prognostic factor for both overall and disease-free survival by multivariate analysis, whereas blood transfusion and the presence of PVTT independently predicted unfavorable overall or disease-free survival, respectively.
CONCLUSIONS: These data indicated that RMH was safe and appeared to be effective in treating cirrhotic patients with HCC. Some tumor-related and clinical variables influenced long-term outcome of these patients after RMH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610113     DOI: 10.1007/s00268-007-9029-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

1.  Liver anatomy: portal (and suprahepatic) or biliary segmentation.

Authors:  C Couinaud
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

2.  Estimating the world cancer burden: Globocan 2000.

Authors:  D M Parkin; F Bray; J Ferlay; P Pisani
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

3.  Evaluation of major hepatic resection for small hepatocellular carcinoma.

Authors:  M Shimada; T Gion; T Hamatsu; Y Yamashita; H Hasegawa; T Utsunomiya; K Takenaka; K Sugimachi
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

4.  Major compared with limited hepatic resection for hepatocellular carcinoma without underlying cirrhosis: a retrospective analysis.

Authors:  N Nagasue; A Yamanoi; O N el-Assal; H Ohmori; M Tachibana; T Kimoto; H Kohno
Journal:  Eur J Surg       Date:  1999-07

5.  Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.

Authors:  R T Poon; S T Fan; C M Lo; I O Ng; C L Liu; C M Lam; J Wong
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

6.  Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma.

Authors:  See-Ching Chan; Chi-Leung Liu; Chung-Mau Lo; Chi-Ming Lam; Ronnie Tung-Ping Poon; Wai-Key Yuen; Sheung-Tat Fan; John Wong
Journal:  Arch Surg       Date:  2003-03

7.  Salvage surgery following downstaging of unresectable hepatocellular carcinoma.

Authors:  Wan-yee Lau; Stephen K W Ho; Simon C H Yu; Eric C H Lai; Choong-tsek Liew; Thomas W T Leung
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

8.  Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes.

Authors:  Lorenzo Capussotti; Andrea Muratore; Paolo Massucco; Alessandro Ferrero; Roberto Polastri; Hedayat Bouzari
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

9.  Longterm prognosis after hepatic resection for small hepatocellular carcinoma.

Authors:  Nobuhiko Shimozawa; Kazuhiro Hanazaki
Journal:  J Am Coll Surg       Date:  2004-03       Impact factor: 6.113

10.  Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis.

Authors:  Brian Hung-Hin Lang; Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Arch Surg       Date:  2003-11
View more
  20 in total

1.  A case of hemocholecyst associated with hemobilia following radiofrequency ablation therapy for hepatocellular carcinoma.

Authors:  Keun Young Shin; Jun Heo; Ji Yeon Kim; Sang Jik Lee; Se Young Jang; Soo Young Park; Min Kyu Jung; Chang Min Cho; Won Young Tak; Young Oh Kweon
Journal:  Korean J Hepatol       Date:  2011-06

2.  Validation of the estimation of physiologic ability and surgical stress (E-PASS) score in liver surgery.

Authors:  Vanessa M Banz; Peter Studer; Daniel Inderbitzin; Daniel Candinas
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

3.  Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.

Authors:  Wei-Feng Shen; Wei Zhong; Feng Xu; Tong Kan; Li Geng; Feng Xie; Cheng-Jun Sui; Jia-Mei Yang
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

4.  Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection.

Authors:  Li Zhou; Jing-An Rui; Da-Xiong Ye; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 5.  Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jeong Il Yu; Hee Chul Park
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

6.  Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study.

Authors:  Yusuke Ogihara; Yoshio Kitazume; Yoshihiro Iwasa; Shinichi Taura; Yoshiro Himeno; Tomo Kimura; Seishi Sawano; Shigehiko Terada; Minoru Tanabe; Yukihisa Saida; Ukihide Tateishi
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

7.  Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.

Authors:  Gudrun Zulehner; Mario Mikula; Doris Schneller; Franziska van Zijl; Heidemarie Huber; Wolfgang Sieghart; Bettina Grasl-Kraupp; Thomas Waldhör; Markus Peck-Radosavljevic; Hartmut Beug; Wolfgang Mikulits
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients.

Authors:  Wen-Tao Kong; Wei-Wei Zhang; Yu-Dong Qiu; Tie Zhou; Jun-Lan Qiu; Wei Zhang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

9.  Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma.

Authors:  Keh M Ng; Tristan D Yan; Deborah Black; Francis C K Chu; David L Morris
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

Review 10.  Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.

Authors:  An-Qiang Wang; Yong-Chang Zheng; Juan Du; Cheng-Pei Zhu; Han-Chun Huang; Shan-Shan Wang; Liang-Cai Wu; Xue-Shuai Wan; Hao-Hai Zhang; Ruo-Yu Miao; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.